Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report

被引:109
|
作者
Comeau, Anne Marie
Accurso, Frank J.
White, Terry B.
Campbell, Preston W., III
Hoffman, Gary
Parad, Richard B.
Wilfond, Benjamin S.
Rosenfeld, Margaret
Sontag, Marci K.
Massie, John
Farrell, Philip M.
O'Sullivan, Brian P.
机构
[1] Cyst Fibrosis Fdn, Bethesda, MD 20814 USA
[2] Univ Massachusetts, Sch Med, New England Newborn Screening Program, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Mike McMorris Cyst Fibrosis Res & Treatment Ctr, Denver, CO 80202 USA
[5] Childrens Hosp, Denver, CO 80218 USA
[6] Univ Wisconsin, State Lab Hyg, Madison, WI USA
[7] Univ Wisconsin, Dept Pediat, Madison, WI USA
[8] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA
[9] Childrens Hosp, Dept Newborn Med, Boston, MA 02115 USA
[10] NHGRI, Behav Res Branch, Bethesda, MD USA
[11] NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bethesda, MD 20892 USA
[12] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
[13] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med, Denver, CO 80202 USA
[14] Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia
[15] Univ Massachusetts, Med Ctr, Dept Pediat, Worcester, MA 01605 USA
关键词
newborn screening; cystic fibrosis; genotype; sweat test; guidelines;
D O I
10.1542/peds.2006-1993
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Newborn screening for cystic fibrosis offers the opportunity for early intervention and improved outcomes. This summary, resulting from a workshop sponsored by the Cystic Fibrosis Foundation to facilitate implementation of widespread high quality cystic fibrosis newborn screening, outlines the steps necessary for success based on the experience of existing programs. Planning should begin with a workgroup composed of those who will be responsible for the success of the local program, typically including the state newborn screening program director and cystic fibrosis care center directors. The workgroup must develop a screening algorithm based on program resources and goals including mechanisms available for sample collection, regional demographics, the spectrum of cystic fibrosis disease to be detected, and acceptable failure rates of the screen. The workgroup must also ensure that all necessary guidelines and resources for screening, diagnosis, and care be in place prior to cystic fibrosis newborn screening implementation. These include educational materials for parents and primary care providers; systems for screening and for providing diagnostic testing and counseling for screen-positive infants and their families; and protocols for care of this unique population. This summary explores the benefits and risks of various screening algorithms, including complex situations that can occur involving unclear diagnostic results, and provides guidelines and sample materials for state newborn screening programs to develop and implement high quality screening for cystic fibrosis.
引用
收藏
页码:E495 / E518
页数:24
相关论文
共 50 条
  • [1] Newborn screening for cystic fibrosis
    Wagener, Jeffrey S.
    Zemanick, Edith T.
    Sontag, Marci K.
    CURRENT OPINION IN PEDIATRICS, 2012, 24 (03) : 329 - 335
  • [2] Cystic Fibrosis Diagnosis and Newborn Screening
    Rosenfeld, Margaret
    Sontag, Marci K.
    Ren, Clement L.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2016, 63 (04) : 599 - +
  • [3] Newborn Screening for Cystic Fibrosis
    Sharp, Jack K.
    Rock, Michael J.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 35 (03) : 107 - 115
  • [4] Newborn Screening for Cystic Fibrosis
    Jack K. Sharp
    Michael J. Rock
    Clinical Reviews in Allergy & Immunology, 2008, 35 : 107 - 115
  • [5] Nationwide newborn screening for cystic fibrosis in Germany
    Heinemann, Mitja L.
    Hentschel, Julia
    Becker, Susen
    Prenzel, Freerk
    Henn, Constance
    Kiess, Wieland
    Tabori, Harold
    Lemke, Johannes
    Ceglarek, Uta
    Thiery, Joachim
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2016, 40 (06): : 373 - 384
  • [6] Update on newborn screening for cystic fibrosis
    Wagener, JS
    Sontag, MK
    Sagel, SD
    Accurso, FJ
    CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (06) : 500 - 504
  • [7] Newborn screening for cystic fibrosis
    Gonska, Tanja
    Ratjen, Felix
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (05) : 619 - 631
  • [8] Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening
    Sermet-Gaudelus, Isabelle
    Mayell, Sarah J.
    Southern, Kevin W.
    JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (05) : 323 - 329
  • [9] Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis A Cystic Fibrosis Foundation Workshop Report
    Torphy, Theodore J.
    Allen, Janet
    Cantin, Andre M.
    Konstan, Michael W.
    Accurso, Frank J.
    Joseloff, Elizabeth
    Ratjen, Felix A.
    Chmiel, James F.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (09) : 1398 - 1406
  • [10] Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
    Sherman, Victoria
    Kondratyeva, Elena
    Kashirskaya, Nataliya
    Voronkova, Anna
    Nikonova, Victoria
    Zhekaite, Elena
    Kutsev, Sergey
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (02)